Literature DB >> 17216297

Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis.

A I Christopoulos1, A A Diamantopoulos, P A Dimopoulos, D S Gumenos, G A Barbalias.   

Abstract

BACKGROUND: Dialysis patients are at increased risk of tuberculosis (TB) and anergy due to attenuated cellular immunity. AIM: To define specific risks of TB in anergic and non-anergic dialysis patients.
METHODS: A total of 272 dialysis patients were enrolled in this prospective study over a 36-month follow-up. Entering the study, participants had Mantoux and 2,4-dinitrochlorobenzene skin tests and their cell-mediated immunity (CMI)-index was estimated. Patients were classified as anergic (CMI-index<or=2 and Mantoux<or=4 mm) or non-anergic. Specific relative risks of TB were then calculated, using data from both the general population and 49 non-uremic health care workers. The independent effect of sex, age and diabetes mellitus was determined using Cox's proportional hazard method.
RESULTS: Among the 116 (42.6%) anergics 13 (11.2%), and among the 156 non-anergics 11 (7%) developed active tuberculosis. Anergics had a significantly higher risk of TB than non-anergics (Adjusted Relative Risks, 98.3, 95% CI 58.65-113.6 versus 61.6, 95% CI 13.6-72.1, P=0.003). Tuberculin reactivity was weakly associated with the subsequent risk of TB (r=0.51). The latter showed a steadily decreasing trend with increasing CMI-index (r=-0.99).
CONCLUSION: Anergy distorts the association of tuberculin reactivity with risk of TB. Anergic dialysis patients are at increased risk of developing active TB and chemoprophylaxis is justified in them too.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17216297     DOI: 10.1007/s11255-006-9051-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Tuberculosis prophylaxis for the chronically dialysed patient--yes or no?

Authors:  A Korzets; U Gafter
Journal:  Nephrol Dial Transplant       Date:  1999-12       Impact factor: 5.992

2.  Tuberculosis in dialyzed patients.

Authors:  R P Pradhan; L A Katz; B D Nidus; R Matalon; R P Eisinger
Journal:  JAMA       Date:  1974-08-12       Impact factor: 56.272

3.  Isoniazid-related fatal hepatitis.

Authors:  P S Millard; T C Wilcosky; S J Reade-Christopher; D J Weber
Journal:  West J Med       Date:  1996-06

4.  Endogenous cell-mediated immunity, blood transfusion, and outcome of renal transplantation.

Authors:  M A Watson; J D Briggs; A A Diamandopoulos; D N Hamilton; H M Dick
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

5.  Factors of delayed hypersensitity in pulmonary tuberculosis.

Authors:  A N Malaviya; K L Sehgal; R Kumar; H B Dingley
Journal:  Am Rev Respir Dis       Date:  1975-07

6.  Isoniazid prophylaxis in hepatitis B carriers.

Authors:  K A McGlynn; E D Lustbader; R G Sharrar; E C Murphy; W T London
Journal:  Am Rev Respir Dis       Date:  1986-10

Review 7.  Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature.

Authors:  M S Siskind; D Thienemann; L Kirlin
Journal:  Nephron       Date:  1993       Impact factor: 2.847

8.  Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area.

Authors:  Hua-Chang Fang; Kang-Ju Chou; Chien-Liang Chen; Po-Tsang Lee; Yee-Hsuan Chiou; Shih-Yuan Hung; Hsiao-Min Chung
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

Review 9.  The immune system in end-stage renal disease.

Authors:  B Descamps-Latscha
Journal:  Curr Opin Nephrol Hypertens       Date:  1993-11       Impact factor: 2.894

10.  The relationship between natural killer cell activity and delayed-type hypersensitivity reaction to 2,4-dinitrochlorbenzene in the spectrum of chronic, intractable pulmonary tuberculosis.

Authors:  T Yoneda; R Mikami; Y Sakaguchi; F Shirai
Journal:  Tubercle       Date:  1987-03
View more
  8 in total

1.  Male-female differences in the risk of tuberculosis in dialysis patients.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Goumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2008-10-24       Impact factor: 2.370

2.  Our war against bacteria in peritoneal dialysis, the last 40 years!

Authors:  Dimitrios G Oreopoulos; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 3.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

4.  Extrapulmonary tuberculosis in a hemodialysis patient with unusual clinical presentation.

Authors:  Tansu Sav; Bulent Tokgoz; Murat H Sipahioglu; Ertugrul Mavili; Oktay Oymak; Cengiz Utas
Journal:  Int Urol Nephrol       Date:  2009-04-29       Impact factor: 2.370

5.  Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients.

Authors:  Ekrem Cengiz Seyhan; Gulşah Gunluoglu; Mehmet Zeki Gunluoglu; Seda Tural; Sinem Sökücü
Journal:  Ann Thorac Med       Date:  2016 Apr-Jun       Impact factor: 2.219

6.  Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial.

Authors:  Antonios I Christopoulos; Athanasios A Diamantopoulos; Panagiotis A Dimopoulos; Demetrios S Goumenos; George A Barbalias
Journal:  BMC Nephrol       Date:  2009-11-07       Impact factor: 2.388

7.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

8.  Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis.

Authors:  Chin-Chung Shu; Vin-Cent Wu; Feng-Jung Yang; Sung-Ching Pan; Tai-Shuan Lai; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.